HSBC HOLDINGS PLC

Position in MDXG — Mimedx Group, Inc.

CIK 873630 LONDON, X0

Position in MDXG

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$637,964

-$296,174 QoQ

Shares Held

161,510

+17.1% QoQ

Ownership

0.108%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $961,918,485 across 122 Biotechnology names. MDXG ranks #51 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	655,443	$292,681,510
2	REGN	Regeneron Pharmaceuticals, Inc.	323,338	$249,823,869
3	RPRX	Royalty Pharma plc	1,544,018	$74,066,541
4	INCY	Incyte Corp	582,368	$54,812,474
5	ALNY	Alnylam Pharmaceuticals, Inc.	89,619	$29,652,235
6	MRNA	Moderna, Inc.	490,088	$24,896,468
7	INSM	INSMED Inc	116,456	$19,042,883
8	PTCT	Ptc Therapeutics, Inc.	227,059	$15,469,528

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$637,964	161,510	+17.1%	Shares	Defined	2026-04-30
2025-12-31	$934,138	137,982	-1.3%	Shares	Defined	2026-03-20
2025-09-30	$975,734	139,790	-8.8%	Shares	Defined	2025-11-13
2025-06-30	$936,724	153,310	+288.4%	Shares	Defined	2025-08-13
2025-03-31	$299,956	39,468	+32.8%	Shares	Defined	2025-05-14
2024-12-31	$285,829	29,712	-30.8%	Shares	Defined	2025-02-14
2024-09-30	$253,651	42,919	+25.0%	Shares	Defined	2024-11-14
2024-06-30	$237,996	34,343	+7.3%	Shares	Defined	2024-08-12
2024-03-31	$246,507	32,014	+34.5%	Shares	Defined	2024-05-15
2023-12-31	$208,717	23,799	+22.3%	Shares	Defined	2024-02-12
2023-09-30	$141,826	19,455	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.